Evidence map›Paper›PMID 35072346›Full record

ArticleChemMedChem2022

Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties.

Maximilian Barth, Stefan Rudolph, Jan Kampschulze, Imke Meyer Zu Vilsendorf, Walburga Hanekamp, Dennis Mulac, Klaus Langer, Matthias Lehr

Open access · hybridAbstract read
In one paragraph

Article in ChemMedChem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Medicinal chemistry (Shariqah (United Arab Emirates)) · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maximilian BarthInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Stefan RudolphInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Jan KampschulzeInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Imke Meyer Zu VilsendorfInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Walburga HanekampInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Dennis MulacInstitute of Pharmaceutical Technology and Biopharmacy, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Klaus LangerInstitute of Pharmaceutical Technology and Biopharmacy, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.
Matthias LehrInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149, Münster, Germany.ORCID 0000-0003-1645-7913
University of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of hexafluoroisopropyl carbamates with indolylalkyl- and azaindolylalkyl-substituents at the carbamate nitrogen was synthesized and evaluated for inhibition of the endocannabinoid degrading enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). The synthesized derivatives with butyl to heptyl spacers between the heteroaryl and the carbamate moiety were inhibitors of both enzymes. For investigated compounds in which the alkyl chain was partially incorporated into a piperidine ring, different results were obtained. Compounds with a methylene spacer between the piperidine ring and the heteroaromatic system were found to be selective MAGL inhibitors, while an extension of the alkyl spacer to two to four atoms resulted in dual inhibition of FAAH/MAGL. The only small change in enzyme inhibitory activity with variation of the heteroaromatic system indicates that the reactive hexafluoroisopropyl carbamate group is mainly responsible for the strength of the inhibitory effect of the compounds. Selected derivatives were also tested for hydrolytic stability in aqueous solution, liver homogenate and blood plasma as well as for aqueous solubility and for permeability in a Caco-2 cell model. Some compounds showed a slightly higher MAGL inhibitory effect than the known selective MAGL inhibitor ABX-1431 and also partly surpassed this substance with regard to certain physicochemical and biochemical properties such as water solubility and cell permeability.

Indexed as

CarbamatesMonoacylglycerol LipasesAmidohydrolasesCaco-2 CellsEnzyme InhibitorsFatty Acid Amide HydrolasesHumansMonoglyceridesPiperidinesAmidohydrolasesCarbamatesEnzyme InhibitorsFatty Acid Amide HydrolasesMonoacylglycerol LipasesMonoglyceridesPiperidinesCaco-2 cell permeationcarbamatefatty acid amide hydrolaseinhibitorsmonoacylglycerol lipase

Identifiers

PMID35072346
PMCPMC9303458
OpenAlexW4207060337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.